Vivani Medical (VANI) Stock Price, News & Analysis

Company Overview

Vivani Medical Solutions, Inc. (NASDAQ: VANI) is a medical technology company focused on the design, development and commercialization of advanced specimen retrieval and hemostasis products for minimally invasive diagnostic procedures. Its core mission is to enhance procedural safety and streamline clinical workflows for interventional radiologists and pathology laboratories.

The company’s flagship offerings include the StopBleed Retrieval Device and StopBleed Pad, which integrate proprietary hemostatic materials to control bleeding at biopsy sites and preserve tissue integrity. These products aim to reduce complications associated with percutaneous biopsies while facilitating efficient sample collection and handling, helping clinicians deliver faster and more accurate diagnoses.

Vivani Medical serves a broad customer base that encompasses hospitals, outpatient imaging centers and pathology service providers across the United States. In addition to its direct‐sales model, the company has established distribution partnerships to extend its reach into select European and Latin American markets, supporting growing international adoption of its technologies.

Founded in 2016 and headquartered in the United States, Vivani Medical became a publicly traded company in mid-2021, listing its common stock on the Nasdaq Capital Market under the ticker symbol “VANI.” The company’s leadership team brings together experienced professionals in medical device innovation, regulatory affairs and commercial operations, driving ongoing efforts to expand its product pipeline and reinforce its position in the interventional radiology market.

Key Stats

• Today's Range: $1.22 to $1.31
• 50-Day Range: $1.15 to $1.62
• 52-Week Range: $0.91 to $1.80
• Volume: 89,631 shs
• Average Volume: 53,379 shs
• Market Capitalization: $72.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Buy

Vivani Medical Stock Analysis - MarketRank™

Vivani Medical scored higher than 55% of companies evaluated by MarketBeat, and ranked 490th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Vivani Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Vivani Medical has a consensus price target of $4.00, representing about 227.9% upside from its current price of $1.22.

Amount of Analyst Coverage

Vivani Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Earnings Growth

Earnings for Vivani Medical are expected to remain at ($0.41) per share in the coming year.

Price to Earnings Ratio vs. the Market

The P/E ratio of Vivani Medical is -2.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Vivani Medical is -2.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Vivani Medical has a P/B Ratio of 4.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.83% of the float of Vivani Medical has been sold short.

Short Interest Ratio / Days to Cover

Vivani Medical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vivani Medical has recently decreased by 32.53%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Vivani Medical does not currently pay a dividend.

Dividend Growth

Vivani Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.83% of the float of Vivani Medical has been sold short.

Short Interest Ratio / Days to Cover

Vivani Medical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vivani Medical has recently decreased by 32.53%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.71

News Sentiment

Vivani Medical has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Vivani Medical this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for VANI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Vivani Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

46.40% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 6.78% of the stock of Vivani Medical is held by institutions.

VANI Stock Analysis - Frequently Asked Questions

How have VANI shares performed this year?

Vivani Medical's stock was trading at $1.16 on January 1st, 2025. Since then, VANI shares have increased by 5.2% and is now trading at $1.22.

How were Vivani Medical's earnings last quarter?

Vivani Medical, Inc. (NASDAQ:VANI) announced its earnings results on Wednesday, August, 13th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.02.

Who are Vivani Medical's major shareholders?

Top institutional investors of Vivani Medical include Tanager Wealth Management LLP (1.72%), Panagora Asset Management Inc. (0.03%) and Group One Trading LLC. Insiders that own company stock include Gregg Williams, Joachim Eberhard Bolck, Aaron Mendelsohn, Donald Dwyer and Brigid Makes.
View institutional ownership trends.

How do I buy shares of Vivani Medical?

Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vivani Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Second Sight Medical Products (EYES), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB).

Company Calendar

• Last Earnings: 8/13/2025
• Today: 9/11/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VANI
• CIK: 1266806
• Web: www.vivani.com
• Phone: (818) 833-5000
• Fax: 818-833-5067
• Employees: 20
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Vivani Medical: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +227.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.45)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.49 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -194.66%
• Return on Assets: -68.64%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.30
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.30 per share
• Price / Book: 4.07

Miscellaneous

• Outstanding Shares: 59,240,000
• Free Float: 31,755,000
• Market Cap: $72.27 million
• Optionable: Optionable
• Beta: 3.12